Open Access Article
This Open Access Article is licensed under a Creative Commons Attribution 3.0 Unported Licence
Expression of concern: Heat-based transdermal delivery of a ramipril loaded cream for treating hypertension
Anna
Voronova
a,
Quentin
Pagneux
a,
Raphael
Decoin
b,
Eloise
Woitrain
b,
Laura
Butruille
b,
Alexandre
Barras
a,
Catherine
Foulon
c,
Marie
Lecoeur
c,
Diego
Jaramillo
d,
José
Rumipamba
d,
Sorin
Melinte
d,
Amar
Abderrahmani
a,
David
Montaigne
b,
Rabah
Boukherroub
a and
Sabine
Szunerits
*a
aUniv. Lille, CNRS, Centrale Lille, Univ. Polytechnique Hauts-de-France, UMR 8520 – IEMN, F-59000 Lille, France. E-mail: sabine.szunerits@univ-lille.fr
bUniv. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011 – EGID, F-59000 Lille, France
cUniv. Lille, CHU Lille, ULR 7365 – GRITA – Groupe de Recherche sur les formes Injectables et Technologies Associées, F-59000 Lille, France
dInstitute of Information and Communication Technologies, Electronics and Applied Mathematics, Université catholique de Louvain, 1348 Louvain-la-Neuve, Belgium
First published on 5th December 2024
Abstract
Expression of concern for ‘Heat-based transdermal delivery of a ramipril loaded cream for treating hypertension’ by Anna Voronova et al., Nanoscale, 2022, 14, 12247–12256, https://doi.org/10.1039/D2NR02295H.
The Royal Society of Chemistry is publishing this expression of concern in order to alert readers that concerns have been raised regarding the reliability of the data. The Royal Society of Chemistry has asked the University of Lille to investigate this matter. An expression of concern will continue to be associated with the article until we receive conclusive evidence regarding the reliability of the reported data.
Heather Montgomery
5th November 2024
Managing Editor, Nanoscale
| This journal is © The Royal Society of Chemistry 2025 |